IFNG and cancer: BEBT-908, a dual PI3K/HDAC inhibitor, induces ferroptosis resulting in increased MCH-1 expression and activation of STAT1/IFNγ signaling in cancer cells, which in turn promotes antitumor immunotherapy [85].